The ratio of ADP- to ATP-ectonucleotidase activity is reduced in patients with coronary artery disease

Thrombosis Research

Volumn 116, Issue 3, 2005, Pages 199-206

  El Omar, Magdi M ^a,b   Islam, Naziba ^b,c   Broekman, M Johan ^b,c   Drosopoulos, Joan H F ^b,c   Roa, Donald C ^a,b   Lorin, Jeffrey D ^a,b   Sedlis, Steven P ^a,b   Olson, Kim E ^b,c   Pulte, E Dianne ^b,c   Marcus, Aaron J ^b,c  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Cardiovascular diseases; Endothelium; Lymphocytes; Platelets; Thrombosis

Indexed keywords

APYRASE; CD39 ANTIGEN; NUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE; NUCLEOTIDASE; UNCLASSIFIED DRUG;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY THROMBOSIS; CORONARY RISK; DEFENSE MECHANISM; DISEASE MARKER; ENZYME ACTIVITY; ENZYME ASSAY; HOST RESISTANCE; HUMAN; LINEAR REGRESSION ANALYSIS; MALE; PREDICTION; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOGENESIS;

ADENOSINE TRIPHOSPHATASES; AGED; ANTIGENS, CD; APYRASE; CARBON RADIOISOTOPES; CASE-CONTROL STUDIES; CHROMATOGRAPHY, THIN LAYER; CORONARY ARTERIOSCLEROSIS; HUMANS; LYMPHOCYTES; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RISK FACTORS;

EID: 18044369921     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2004.11.024     Document Type: Article

References (38)

1. H.C. Stary, A.B. Chandler, S. Glagov, J.R. Guyton, W. Insull Jr., and M.E. Rosenfeld A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the committee on vascular lesions of the council on arteriosclerosis, American Heart Association Circulation 89 1992 2462 2478
2. D.G. Hackam, and S.S. Anand Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidence JAMA 290 2003 932 940
3. D.L. Bhatt, and E.J. Topol Need to test the arterial inflammation hypothesis Circulation 106 2002 136 140
4. P. Libby, P.M. Ridker, and A. Maseri Inflammation and atherosclerosis Circulation 105 2002 1135 1143
5. R. Ross Mechanisms of disease: atherosclerosis-an inflammatory disease N. Engl. J. Med. 340 1999 115 126
6. D. Behrendt, and P. Ganz Endothelial function. From vascular biology to clinical applications Am. J. Cardiol. 90 2002 40L 48L
7. P.O. Bonetti, L.O. Lerman, and A. Lerman Endothelial dysfunction: a marker of atherosclerotic risk Arterioscler. Thromb. Vasc. Biol. 23 2003 168 175
8. A.J. Marcus, M.J. Broekman, J.H.F. Drosopoulos, N. Islam, D.J. Pinsky, and C. Sesti Metabolic control of excessive extracellular nucleotide accumulation by CD39/ecto-nucleotidase-1: implications for ischemic vascular diseases J. Pharmacol. Exp. Ther. 305 2003 9 16
9. G. Russo, J.A. Leopold, and J. Loscalzo Vasoactive substances: nitric oxide and endothelial dysfunction in atherosclerosis Vasc. Pharmacol. 38 2002 259 269
10. H. Zimmermann Ectonucleotidases: some recent developments and a note on nomenclature Drug Dev. Res. 52 2001 44 56
11. H. Zimmermann Extracellular metabolism of ATP and other nucleotides Naunyn-Schmiedeberg's Arch. Pharmacol. 362 2000 299 309
12. M. Rowe, J.E. Hildreth, A.B. Rickinson, and M.A. Epstein Monoclonal antibodies to Epstein-Barr virus-induced, transformation-associated cell surface antigens: binding patterns and effect upon virus-specific T-cell cytotoxicity Int. J. Cancer 29 1982 373 381
13. G.S. Kansas, G.S. Wood, and T.F. Tedder Expression, distribution, and biochemistry of human CD39. Role in activation-associated homotypic adhesion of lymphocytes J. Immunol. 146 1991 2235 2244
14. C.R. Maliszewski, G.J. Delespesse, M.A. Schoenborn, R.J. Armitage, W.C. Fanslow, and T. Nakajima The CD39 lymphoid cell activation antigen. Molecular cloning and structural characterization J. Immunol. 153 1994 3574 3583
15. E. Kaczmarek, K. Koziak, J. Sévigny, J.B. Siegel, J. Anrather, and A.R. Beaudoin Identification and characterization of CD39 vascular ATP diphosphohydrolase J. Biol. Chem. 271 1996 33116 33122
16. A.J. Marcus, M.J. Broekman, J.H.F. Drosopoulos, N. Islam, T.N. Alyonycheva, and L.B. Safier The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39 J. Clin. Invest. 99 1997 1351 1360
17. M. Imai, K. Takigami, O. Guckelberger, E. Kaczmarek, E. Csizmadia, and F.H. Bach Recombinant adenoviral mediated CD39 gene transfer prolongs cardiac xenograft survival Transplantation 70 2000 864 870
18. S.P. Gangadharan, M. Imai, K.K. Rhynhart, J. Sevigny, S.C. Robson, and M.S. Conte Targeting platelet aggregation: CD39 gene transfer augments nucleoside triphosphate diphosphohydrolase activity in injured rabbit arteries Surgery 130 2001 296 303
19. D.J. Pinsky, M.J. Broekman, J.J. Peschon, K.L. Stocking, T. Fujita, and R. Ramasamy Elucidation of the thromboregulatory role of CD39/ectoapyrase in the ischemic brain J. Clin. Invest. 109 2002 1031 1040
20. L. Belayev, L. Khoutorova, T.A. Deisher, A. Belayev, R. Busto, and Y. Zhang Neuroprotective effect of SolCD39, a novel platelet aggregation inhibitor, on transient middle cerebral artery occlusion in rats Stroke 34 2003 758 763
21. K. Enjyoji, J. Sévigny, Y. Lin, P.S. Frenette, P.D. Christie, and J.S. Esch Targeted disruption of CD39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation Nat. Med. 5 1999 1010 1017
22. A.D. Michelson, and M.I. Furman Laboratory markers of platelet activation and their clinical significance Curr. Opin. Hematol. 6 1999 342 348
23. A.J. Marcus, M.J. Broekman, L.B. Safier, H.L. Ullman, N. Islam, and C.N. Serhan Formation of leukotrienes and other hydroxy acids during platelet-neutrophil interactions in vitro Biochem. Biophys. Res. Commun. 109 1982 130 137
24. A.J. Marcus, L.B. Safier, K.A. Hajjar, H.L. Ullman, N. Islam, and M.J. Broekman Inhibition of platelet function by an aspirin-insensitive endothelial cell ADPase. Thromboregulation by endothelial cells J. Clin. Invest. 88 1991 1690 1696
25. R.B. Gayle III, C.R. Maliszewski, S.D. Gimpel, M.A. Schoenborn, R.G. Caspary, and C. Richards Inhibition of platelet function by recombinant soluble ecto-ADPase/CD39 J. Clin. Invest. 101 1998 1851 1859
26. 2+ utilization by soluble human CD39/ecto-nucleotidase Arch. Biochem. Biophys. 406 2002 85 95
27. J.H.F. Drosopoulos, M.J. Broekman, N. Islam, C.R. Maliszewski, R.B. Gayle III, and A.J. Marcus Site-directed mutagenesis of human endothelial cell ecto-ADPase/soluble CD39. Requirement of glutamate174 and serine218 for enzyme activity and inhibition of platelet recruitment Biochemistry 39 2000 6936 6943
28. A.V. Birk, M.J. Broekman, E.M. Gladek, H.D. Robertson, J.H. Drosopoulos, and A.J. Marcus Role of extracellular ATP metabolism in regulation of platelet reactivity J. Lab. Clin. Med. 140 2002 166 175
29. P.M. Evans Inhibition of ADP-induced aggregation of human platelets by beta, gamma-methylene-ATP Cytobios 23 1978 101 108
30. Y. Kawashima, T. Nagasawa, and H. Ninomiya Contribution of ecto-5′-nucleotidase to the inhibition of platelet aggregation by human endothelial cells Blood 96 2000 2157 2162
31. D.E. Macfarlane, and D.C. Mills The effects of ATP on platelets: evidence against the central role of released ADP in primary aggregation Blood 46 1975 309 320
32. K. Yamamoto, R. Korenaga, A. Kamiya, Z. Qi, M. Sokabe, and J. Ando P2X4 receptors mediate ATP-induced calcium influx in human vascular endothelial cells Am. J. Physiol., Heart Circ. Physiol. 279 2000 H285 H292
33. J. Sevigny, C. Sundberg, N. Braun, O. Guckelberger, E. Csizmadia, and I. Qawi Differential catalytic properties and vascular topography of murine nucleoside triphosphate diphosphohydrolase 1 (NTPDase1) and NTPDase2 have implications for thromboregulation Blood 99 2002 2801 2809
34. T.M. Smith, and T.L. Kirley Cloning, sequencing, and expression of a human brain ecto-apyrase related to both the ecto-ATPases and CD39 ecto-apyrases Biochim. Biophys. Acta 1386 1998 65 78
35. F. Yang, C.A. Hicks-Berger, T.M. Smith, and T.L. Kirley Site-directed mutagenesis of human nucleoside triphosphate diphosphohydrolase 3: the importance of residues in the apyrase conserved regions Biochemistry 40 2001 3943 3950
36. T.L. Kirley, F. Yang, and V.V. Ivanenkov Site-directed mutagenesis of human nucleoside triphosphate diphosphohydrolase 3: the importance of conserved glycine residues and the identification of additional conserved protein motifs in eNTPDases Arch. Biochem. Biophys. 395 2001 94 102
37. G.I. Lunkes, D. Lunkes, F. Stefanello, A. Morsch, V.M. Morsch, and C.M. Mazzanti Enzymes that hydrolyze adenine nucleotides in diabetes and associated pathologies Thromb. Res. 109 2003 189 194
38. H.D. Orzechowski Anti-platelet function of human endothelial cells: augmentation by angiotensin-converting enzyme inhibitors? J. Hypertens. 21 2003 1259 1261